Press Releases

Huateng Pharma Announced To Attend CPhI China In June 2023

Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

CD Formulation Exhibits Proficiency in Contact Angle Determination of Pharmaceutical Excipients

Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, has announced its membership in the Coalition for Epidemic Preparedness Innovations (CEPI) esteemed Central Lab Network, to improve global epidemic preparedness. CEPI is an innovative partnership between public, private, philanthropic, and civil organizations to develop vaccines against future epidemics. This strategic partnership represents a significant milestone in Synexa's commitment to global health security and its dedication to fostering collaboration and innovation in epidemic preparedness and response.

Creative Enzymes Elevates Your Industrial Processes with Enzymes for Industrial Use

Creative Enzymes Revolutionizes the Probiotics Industry with Bacillus Coagulans Freeze Dried Powder

Mural Health and China-based Clinflash Partner to Expand Global Patient Payment Solutions

Oncodesign Services and Veritas In Silico enter into business cooperation on developing mRNA-targeted small molecule drugs

Oncodesign Services has announced it has entered into a Memorandum of Understanding with Veritas In Silico to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting mRNA.

New Partnership Established: Alfa Chemistry Adds 200,000+ Chemicals to Spaya Database

Next-Generation eCOA/ePRO Provider uMotif Welcomes SAFIRA Clinical Research Co-founder and Clinical Trial Technology Innovator Willie Muehlhausen as Scientific Advisor

Muehlhausen is a trusted name in independent, scientific evaluation of patient-facing technologies; also known for his ability to envision and develop groundbreaking solutions for eCOA/ePRO and wearables.

Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development

Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing.

Neutec Group Introduces the oCelloscope Automated Microbial Live-Cell Imaging technology, by Biosense Solutions

Neutec Group has announced its new distribution partnership with the DK based Biosense Solutions, the manufacturer of the oCelloScope™ technology used globally in a wide variety of microbial applications.

Inizio Targets Innovation and AI-Led Growth with Two Top Appointments

Global strategic advisory agency Inizio has announced two senior leadership appointments to its Inizio Medical division, strengthening the AI and innovation capabilities of the business.

Alfa Chemistry’s Laboratory Increases Capability for Water Analysis, Resin Analysis, and Chromatography Analysis

Celerion Receives a 2023 CRO Leadership Award in All Categories for the Eighth Year Running

AMP Offers Evidence-Based Recommendations for Next-Generation Sequencing Germline Variant Confirmation

New AMP report offers recommendations for NGS germline variant confirmation

CD Genomics Harnesses Single-cell DNA Methylation Sequencing Service to Drive Scientific Breakthroughs

CD Genomics Expands Services with Pre-made Library Sequencing for High-Throughput Analysis

CD Genomics Unveils Cutting-Edge Long-Read Metagenomic Sequencing Service

CTMC AWARDED $9.1M THROUGH CPRIT GRANT FOR THE ADVANCEMENT OF CELL THERAPY

CTMC, a joint venture between Resilience + MD Anderson Cancer Center, announces that it has been awarded $9.1M in the newly created Cancer Prevention & Research Institute of Texas (CPRIT) Texas New Technologies Company grant. The grant will focus on retroviral vector (RVV) manufacturing, an enhanced tumor-infiltrating lymphocytes (TIL) platform, and a differentiated process development approach to CAR-T manufacturing.

Vitality of Hyaluronic acid, L-vitamin C, Coenzyme Q10, Alpha hydroxy acid, and Hexapeptide